Mdkhana [81] et al. demonstrated that the STING pathway is involved in the COPD pathogenesis, which indicates that the combination of STING inhibitor and steroid could be a viable treatment option. The gene discussed is STING1; the disease is chronic obstructive pulmonary disease.